F-18-Fdg Pet/Ct Findings in Differentiated Papillary Carcinoma of Thyroid and Determination of Metabolic Activity

Basit Öğe Kaydı
dc.contributor.authorTezel, Mehmet Oğulcan
dc.contributor.authorMercan, Oğuz
dc.contributor.authorYumurtacı, Öznur
dc.contributor.authorKurt, Cansu
dc.contributor.authorAltun, Gülay Durmuş
dc.date.accessioned2021-11-20T10:26:28Z
dc.date.available2021-11-20T10:26:28Z
dc.date.issued2017
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Ortopedi ve Travmatoloji Anabilim Dalıen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Anabilim Dalıen_US
dc.description.abstractAims: In well differentiated thyroid cancers, FDG PET has a relatively low sensitivity. F-18 FDG PET/CT is an imaging method which is used before the treatment and in high risk patient groups with suspected recurrent disease. In this study we aim to determine the character of metabolic activity in differentiated thyroid cancer and in case of metastasis and to evaluate the findings of F-18-FDG PET/CT images in high risk patient group of differentiated thyroid cancer. Methods: The data of 79 patients who underwent imaging for staging or restaging and followed at Trakya Univerısity Faculty of Medicine from 2010 to 2015, were included in this study. Patient reports were analyzed retrospectively. Age, gender, size of thyroid lesion, presence of lymphadenopathy, other organ metastases (lung, liver, brain, bone) were included in the study. Results: The findings of 79 patients (29 male, 50 female) with papillary differentiated thyroid cancer were included in the analyses. The mean age of participants was 51±15 years. 14 patients (18%) were evaluated as normally. Recurırent disease was detected in the thyroid gland of 10 patients (13%) (SUVmax: 6.2±5.1; 2.3-19.3). In 54 patients (68%) lymph node metastasis was detected (SUVmax; 5.8±5.1; 2.1-24.2). 12 patients had liver metastasis (SUVmax: 5.7±3.9; 2.0-11.7), 12 patients had bone metastasis (SUVmax: 6.1±2.9; 2.2-13.9), 8 patients had lung metastasis (SUVmax: 4.3±4.5; 1.0-4.9) and one patient had brain metastasis (SUVmax: 10.2). Conclusion: Papillary differentiated thyroid cancer is associated with a tumor showing low glucose affinity, but it is understood that the tumor changes its behavior and gets metabolically active in the patients within the high risk group and in those with systemic metastasisen_US
dc.identifier.dergipark379076en_US
dc.identifier.endpage50en_US
dc.identifier.issn2148-4724
dc.identifier.issn2548-0030
dc.identifier.issue3en_US
dc.identifier.startpage47en_US
dc.identifier.urihttps://dergipark.org.tr/tr/pub/tmsj/issue/34308/379076
dc.identifier.urihttps://dergipark.org.tr/tr/download/article-file/404714
dc.identifier.urihttps://hdl.handle.net/20.500.14551/6057
dc.identifier.volume4en_US
dc.language.isoenen_US
dc.publisherTrakya Üniversitesien_US
dc.relation.ispartofTurkish Medical Student Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectThyroid canceren_US
dc.subjectF-18 FDGen_US
dc.subjectPET/CTen_US
dc.titleF-18-Fdg Pet/Ct Findings in Differentiated Papillary Carcinoma of Thyroid and Determination of Metabolic Activityen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
6057.pdf
Boyut:
288.12 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Turkish Medical Student Journal
Makale Koleksiyonu
Makale Koleksiyonu